Chemicals

Fluorobenzene

We are Fluorobenzene CAS:462-06-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 462-06-6

Product Name: Fluorobenzene

Other Name:

Fluorobenzene

Monofluorobenzene

Monofluoro boroxine

4-Fluorobenzene

Monofluorboroxin

Density: 1.0±0.1 g/cm3

Boiling Point: 84.7±9.0 °C at 760 mmHg

Melting Point: -42 °C

Molecular Formula: C6H5F

Molecular Weight: 96.102

Flash Point: -12.8±0.0 °C

Exact Mass: 96.037529

LogP: 2.27

Vapour density: 3.31 (vs air)

Vapour Pressure: 79.9±0.1 mmHg at 25°C

Index of Refraction: 1.473

Stability: Stable. Incompatible with oxidizing agents. Highly flammable – note low flash point.

Water Solubility: INSOLUBLE

Specification

Appearance: Colorless liquid

Assay: ≥98.0%

Water: ≤0.50%

Application

It is mainly used for the main anti-psychotic drugs such as fluorobutanol, darofene benzene, trifluoropiperidine, trifluoropiperidine benzene, penfluridol and quinolone-ciprofloxacin.

It is also used for the identification of pesticides and ovicides and plastics and resin polymers.

The condensation of fluorobenzene with γ-chlorobutyryl chloride can produce γ-chloro-p-fluorobutanone, which is used in the synthesis of haloperidol, and is the most commonly used drug for butyrophenone antipsychotics.

Applicationd as insecticide, ovicide, and for the identification of plastics and resin polymers.

Package: 25kg/drum, can also be designed according to customer requirements.

Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Fluorobenzene

Related News: In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.49660-57-3 The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.3-Chloro-6-(trifluoromethyl)pyridazine The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.4-Fluoro-3-methylbenzaldehyde CAS:135427-08-6 The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations.Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.

Product Name
4-Biphenylboronic acid Cas:5122-94-1	View Details
bis(benzonitrile)platinum(Ⅱ)chloride Cas:14873-63-3	View Details
1,9-NONANEDIOL Cas:3937-56-2	View Details